Skip to main content
SpringerLink
Log in

Gender-related hormonal risk factors for oral cancer

  • Article
  • Published:
Pathology & Oncology Research

Abstract

Oral cancer (OC) is a neoplasm with fairly high male to female ratio in most populations. The conspicuously lower incidence of this tumor among women than man is suggestive of certain endocrine involvement in its development. The aim of the present case-control study was to clarify the origin of this gender-specific risk of OC incidence. 2660 inpatients (530 females and 2130 males) with squamous cell OC at the Department of Oral and Maxillofacial Surgery were included in a case-control study. Smoking, alcohol consumption, elevated fasting serum glucose level and menopausal histories of female cases were registered. Smoking and excessive alcohol intake proved to be strong risk factors for OC both in the male and female group. However, moderate alcohol consumption was a weaker risk factor for male patients, and it presented no risk for female cases. Elevated fasting glucose level was not a demonstrable OC risk factor among males, however, it proved to be strong risk factor for OC among female patients, especially in gingival cancer cases. The almost exclusively postmenopausal state of female OC patients and the long mean interval (17 years) between their menopause and OC diagnosis suggested an important role of estrogen deficiency in OC epidemiology. The significantly younger mean age at menopause and the significantly higher rate of hysterectomy among female OC cases in comparison with their controls also support the estrogen deficiency hypothesis. This novel hypothesis of estrogen deficiency and elevated fasting glucose as risk factors for OC in postmenopausal women may provide new insights into the etiology of oral malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Neville BW, Day TA: Tumors and precancerous lesions of the oral cavity. CA Cancer J Clin 52: 195–215, 2002

    PubMed  Google Scholar 

  2. La Vecchia C, Lucchini F, Negri E et al: Trends in oral cancer mortality in Europe. Oral Oncol 40: 433–439, 2004

    Article  PubMed  Google Scholar 

  3. Krolls SO, Hoffman S: Squamous cell carcinoma of the oral soft tissues: a statistical analysis of 14,253 cases by age, sex and race of patients. JADA 92: 571–574, 1976

    CAS  PubMed  Google Scholar 

  4. Rich AM, Radden BG: Squamous cell carcinoma of the oral mucosa: a review of 244 cases in Australia. J Oral Pathol 13: 459–471, 1984

    Article  CAS  PubMed  Google Scholar 

  5. Levi F, Lucchini F, Negri E et al: Trends in cancer mortality in the European Union and accession countries, 1980–2000. Ann Oncol 15: 1425–1431, 2004

    Article  CAS  PubMed  Google Scholar 

  6. Johnson NW: Etiology and risk factors for oral cancers and their correlations with smoking and alcohol consumption. Hung Oncol (in Hungarian) 45: 115–122, 2001

    Google Scholar 

  7. Suba Z, Barabás J: Prevention of oral cancer (in Hungarian). Medicina ZRT, Budapest, 2007, pp. 15–20

    Google Scholar 

  8. Ujpál M, Matos O, Bíbok G, et al: Diabetes and oral tumors in Hungary: Epidemiological correlations. Diabetes Care 27: 770–774, 2004.

    Article  PubMed  Google Scholar 

  9. Suba Z, Barabás J, Szabá G, et al: Increased prevalence of diabetes and obesity in patients with salivary gland tumors. Diabetes Care 28: 228, 2005

    Article  PubMed  Google Scholar 

  10. Mealey BL, Moritz AJ: Hormonal influences: effects of diabetes mellitus and endogenous female sex steroid hormones on the periodontium. Periodontol 2000 32: 59–81, 2003

    Article  Google Scholar 

  11. Eliasson B, Attval S, Taskinen MR, et al: The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb 14: 1946–1950, 1994

    CAS  PubMed  Google Scholar 

  12. Sierksma A, Patel H, Ouchi N, et al: Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor alpha and insulin sensitivity. Diabetes Care 24: 184–189, 2004

    Article  Google Scholar 

  13. Beulens JW, Stolk RP, van der Schouw YT et al: Alcohol consumption and risk of type-2 diabetes among older women. Diabetes Care 28: 2933–2938, 2005

    Article  PubMed  Google Scholar 

  14. Nestler JE: Obesity, insulin, sex steroids and ovulation. Int J Obes Relat Metab Disord 24 (Suppl 2): S71-S73, 2000

    Article  CAS  PubMed  Google Scholar 

  15. Huber JC, Schneeberger C, Tempfer CB: Genetic modelling of the estrogen metabolism as risk factor of hormone-dependent disorders. Maturitas 42: 1–12, 2002

    Article  CAS  PubMed  Google Scholar 

  16. Liehr JG: Is estradiol a genotoxic mutagenic carcinogen? Endocrine Rev 21: 40–54, 2000

    Article  CAS  Google Scholar 

  17. Fernandez E, Gallus S, Bosetti C et al: Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer 105: 408–412, 2003

    Article  CAS  PubMed  Google Scholar 

  18. Diamanti-Kandarakis E: Hormone replacement therapy and risk of malignancy. Curr Opin Obstet Gynecol 16: 73–78, 2004

    Article  PubMed  Google Scholar 

  19. Ettinger B, Friedman GD, Bush T, Qusenberry CP, Jr: Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 87: 6–12, 1996

    Article  CAS  PubMed  Google Scholar 

  20. Gallus S, Bosetti C, Franceschi S et al: Oesophageal cancer in women: tobacco, alcohol, nutritional and hormonal factors. Br J Cancer 85: 341–345, 2001

    Article  CAS  PubMed  Google Scholar 

  21. La Vecchia C, D’Avanzo B, Franceschi S et al: Menstrual and reproductive factors and gastric-cancer risk in women. Int J Cancer 59: 761–764, 1994

    Article  PubMed  Google Scholar 

  22. Parazzini F, La Vecchia C, Negri E et al: Case-control study of estrogen replacement therapy and risk of cervical cancer. Br Med J 315: 85–88, 1997

    CAS  Google Scholar 

  23. Grodstein F, Clarkson T, Manson J: Understanding the divergent data on postmenopausal hormone therapy. N Eng J Med 348: 645–650, 2003

    Article  Google Scholar 

  24. Olsson H, Bladström AM, Ingvar C: Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol 102: 565–570, 2003

    Article  CAS  PubMed  Google Scholar 

  25. Reckelhoff JF: Sex steroids, cardiovascular disease, and hypertension. Hypertension 45: 170–180, 2005

    Article  CAS  PubMed  Google Scholar 

  26. Austad SN: Why women live longer than men: Sex differences in longevity. Gender Med 3: 79–92, 2006

    Article  Google Scholar 

  27. Ebbert JO, Janney CA, Sellers TA et al: The association of alcohol consumption with coronary heart disease mortality and cancer incidence varies by smoking history. J Gener Intern Med 20: 14–20, 2005

    Article  Google Scholar 

  28. McGrath M, Michaud DS, De Vivo I: Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol 163: 236–244, 2006

    Article  PubMed  Google Scholar 

  29. Gago-Domingez M, Castelao JE, Yuan JM et al: Increased risk of renal cell carcinoma subsequent to hysterectomy. Cancer Epidemiol Biomarkers Prev 8: 999–1003, 1999

    Google Scholar 

  30. Faustini-Fustini M, Rochira V, Carani C: Oestrogen deficiency in men: where are we today? Eur J Endocrinol 140: 111–129, 1999

    Article  CAS  PubMed  Google Scholar 

  31. McKeown-Eyssen G: Epidemiology of colorectal cancer revisited: are serum triglycérides and plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3: 687–695, 1994

    CAS  PubMed  Google Scholar 

  32. Everhart J, Wright D: Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis. JAMA 273: 1605–1609, 1995

    Article  CAS  PubMed  Google Scholar 

  33. Balkau B, Kahn H, Courbon D et al: Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: The Paris Prospective Study. Diabetes Care 24: 843–849, 2001

    Article  CAS  PubMed  Google Scholar 

  34. Yeung NG, Husain I, Waterfall N: Diabetes mellitus and bladder cancer — An epidemiological relationship? Pathol Oncol Res 9: 30–31, 2003

    Article  Google Scholar 

  35. Barnard RJ, Aronson WJ, Tymchuk CN et al: Prostate cancer: another aspect of the insulin-resistance syndrome. Obes Rev 3: 303–308, 2002

    Article  CAS  PubMed  Google Scholar 

  36. Muti P, Quattrin T, Grant BJB et al: Fasting glucose is a risk factor for breast cancer. Cancer Epidemiol Biomarkers Prev 11: 1361–1368, 2002

    CAS  PubMed  Google Scholar 

  37. Key TJ, Applyby PN, Reeves GK: Body mass index, serum sex hormones and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95: 1218–1226, 2003

    Article  CAS  PubMed  Google Scholar 

  38. Soliman PT, Oh JC, Schmeler KM et al: Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 105: 575–580, 2005

    PubMed  Google Scholar 

  39. Solomon CG, Hu FB, Dunaif A et al: Long or highly irregular menstrual cycles as a marker for risk of type-2 diabetes mellitus. JAMA 286: 2421–2426, 2001

    Article  CAS  PubMed  Google Scholar 

  40. Bloomgarden ZT: Second World Congress on the Insulin Resistance Syndrome: Mediators, pédiatric insulin resistance, the polycystic ovary syndrome, and malignancy. Diabetes Care 28: 1821–1830, 2005

    Article  PubMed  Google Scholar 

  41. Godsland IF: Oestrogens and insulin secretion. Diabetologia 48: 2213–2220, 2005

    Article  CAS  PubMed  Google Scholar 

  42. Jones ME, Thorburn AW Britt KL et al: Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97: 12735–12740, 2000

    Article  CAS  PubMed  Google Scholar 

  43. Gadducci A, Gargini A, Palla E et al: Polycystic ovary syndrome and gynecological cancers: is there a link? Gynecol Endocrinol 20: 200–208, 2005

    Article  PubMed  Google Scholar 

  44. Freiberg MS, Cabrai HJ, Heeren TC: Alcohol consumption and the prevalence of the metabolic syndrome in the US.: A cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care 27: 2954–2959, 2004

    Article  PubMed  Google Scholar 

  45. Onland-Moret NC, Peeters PHM, van der Schouw YT et al: Alcohol and endogenous sex steroid levels in postmenopausal women: A Cross-Sectional Study. J Clin Endocrinol Metab 90: 1414–1419, 2005

    Article  PubMed  CAS  Google Scholar 

  46. Tavani A, Gallus S, La Vecchia C et al: Diet and risk of oral and pharyngeal cancer. An Italian case-control study. Eur J Cancer Prev 10: 191–195, 2001

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, Oral Pathology Unit, Semmelweis University, Mária u. 52, H-1085, Budapest, Hungary

    Zsuzsanna Suba

Authors
  1. Zsuzsanna Suba
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zsuzsanna Suba.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suba, Z. Gender-related hormonal risk factors for oral cancer. Pathol. Oncol. Res. 13, 195–202 (2007). https://doi.org/10.1007/BF02893499

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02893499

Key words

Search

Navigation